Back/Exponent's Neurelis Highlights Epilepsy Awareness at Sofie's Journey Expo 2025
pharma·November 13, 2025·expo

Exponent's Neurelis Highlights Epilepsy Awareness at Sofie's Journey Expo 2025

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • Neurelis will showcase VALTOCO® at the 13th Annual Sofie's Journey Epilepsy Awareness Expo on November 10-11, 2025.
  • Ambassador Lowell will share his epilepsy journey and VALTOCO's impact on November 11, fostering community understanding.
  • Neurelis emphasizes its commitment to supporting the epilepsy community through education and personal stories throughout the year.

Neurelis to Spotlight Epilepsy Awareness at Annual Expo

Neurelis, Inc. is set to make a significant impact at the 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo, scheduled for November 10-11, 2025, at Disneyland. This event, part of November's National Epilepsy Awareness Month, serves as a vital platform for enhancing education and support for individuals with epilepsy. Neurelis, known for its innovative VALTOCO® (diazepam nasal spray), will focus on sharing valuable insights and experiences that resonate with the epilepsy community. By participating in this expo, Neurelis aims to deepen its commitment to improving the quality of life for those affected by epilepsy.

One of the highlights of Neurelis’s participation is a presentation by Ambassador Lowell, an adult living with epilepsy. Scheduled for November 11 from 11:00 to 11:30 AM, Lowell will recount his personal journey with epilepsy and discuss how VALTOCO has played a pivotal role in managing his condition. This session is designed to foster understanding and support among individuals living with epilepsy, their families, and healthcare practitioners. The presentation will be followed by a Q&A session, allowing attendees to engage directly with Lowell and gain further insights into living with this challenging condition.

In addition to Lowell’s presentation, Neurelis will also feature Ambassador Esteban at a dinner for families on November 10. Esteban, who has navigated surgery and medication changes, will share his empowering journey and emphasize how VALTOCO has helped him regain independence and peace of mind. These personal stories underscore Neurelis’s dedication to supporting individuals with epilepsy, as expressed by Founder and CEO Craig Chambliss. The event, co-sponsored by the Epilepsy Alliance of America, aims to raise awareness and foster community support, making a meaningful contribution to the lives of those affected by epilepsy.

As Neurelis actively participates in the expo, the company not only promotes its product but also strengthens its role as a supportive partner within the epilepsy community. By sharing personal experiences and insights, Neurelis aims to empower individuals living with epilepsy to lead fulfilling lives despite their challenges. The engagement with the epilepsy community at the expo reflects Neurelis’s broader mission of enhancing quality of life through innovative healthcare solutions.

In addition to the expo, Neurelis continues to advocate for epilepsy awareness throughout the year. Their involvement in initiatives that promote education and community support is essential in addressing the unique challenges faced by individuals with epilepsy. By creating platforms for sharing experiences and fostering dialogue, Neurelis helps to build a stronger, more informed community.